Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene

Jun 01, 2016, 08:20 ET from Chelmsford Park SA

NEW YORK, June 1, 2016 /PRNewswire/ --

In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:


On Tuesday, shares in Bruker Corp. ended the session at $26.40, which was a slight correction of 0.30%. The Company, together with its subsidiaries, designs and manufactures scientific instruments, and analytical and diagnostic solutions worldwide. The stock recorded a trading volume of 766,993 shares. The Company's shares have advanced 8.94% since the start of this year. The stock is trading 14.49% above its 200-day moving average. Moreover, shares of Bruker have a Relative Strength Index (RSI) of 38.48. Sign up and read the alert on BRKR at:


Quintiles Transnational Holdings Inc.'s shares gained 1.78%, to close the day at $67.89. The stock recorded a trading volume of 1.85 million shares, which was higher than its three months average volume of 1.07 million shares. The Company's shares have advanced 3.87% in the previous three months. The stock is trading 0.71% above its 50-day moving average and 0.23% above its 200-day moving average. Additionally, shares of Quintiles Transnational Holdings have an RSI of 55.99. The Company was founded in 1982 and is based in Durham, North Carolina. The complimentary technical alert on Q can be turned on at:


Shares in Beijing headquartered preventive healthcare solutions provider, iKang Healthcare Group Inc., recorded a trading volume of 684,466 shares at the close of the last trading session, which was above their three months average volume of 552,430 shares. The stock ended the day 3.32% higher at $19.90. The Company's shares are trading above their 200-day moving average by 6.56%. Furthermore, iKang Healthcare Group's stock has an RSI of 53.17. Register for free on ActiveWallSt.com and access key information on KANG at:


California headquartered molecular diagnostic Company, TrovaGene Inc.'s stock finished yesterday's session 0.75% lower at $5.27 and with a total volume of 279,009 shares traded. The Company's shares have advanced 31.09% in the last one month. The stock is trading above its 50-day and 200-day moving averages by 8.54% and 1.26%, respectively. Furthermore, shares of TrovaGene have an RSI of 62.53.  TROV alerts are available for free at:



Active Wall Street: 

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

AWS has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly at: Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom Email: info@activewallst.com Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA